Amneal Pharmaceuticals, Inc. Class A Common Stock

AMRXNASDAQUSD
16.34 USD
1.02 (6.66%)AT CLOSE (11:59 AM EDT)
16.40
0.06 (0.37%)
POST MARKET (AS OF 04:11 PM EDT)
Post Market
AS OF 04:11 PM EDT
16.40
0.06 (0.37%)
🟢Market: OPEN

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trades at $16.40 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, AMRX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 11, 2026.

Open?$15.47
High?$16.35
Low?$15.33
Prev. Close?$15.32
Volume?3.0M
Avg. Volume?1.7M
VWAP?$15.89
Rel. Volume?1.81x
Bid / Ask
Bid?$13.95 × 100
Ask?$18.46 × 100
Spread?$4.51
Midpoint?$16.21
Valuation & Ratios
Market Cap?4.9B
Shares Out?319.0M
Float?169.5M
Float %?53.2%
P/E Ratio?40.02
P/B Ratio?-107.63
EPS?$0.38
Dividend?0.94%
Ex-Dividend?N/A
News
Profile
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Employees
8.5K
Market Cap
4.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-05-07
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
45
Momentum?
92
Short Sent.?
74
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.27Grey
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?4.44%Low
Short Interest?7.5M
Days to Cover?4.6
Free Float169.5M
Avg Daily Volume1.6M
Settlement Date2026-05-29
Financial Health
Current Ratio?2.46Strong
Quick Ratio?1.58Adequate
Cash Ratio?0.27Low
Debt/Equity?-57.92Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
Peers
100
S&P
18
40.0PRICEY
P/B?
S&P
97
-107.63CHEAP
P/S?
Peers
100
S&P
76
1.60CHEAP
P/FCF?
Peers
100
S&P
55
20.2FAIR
EV/EBITDA?
Peers
100
S&P
72
11.3CHEAP
EV/Sales?
Peers
100
S&P
69
2.40CHEAP
Returns & Efficiency
ROE?
S&P
3
-268.9%WEAK
ROA?
Peers
50
S&P
31
3.5%FAIR
Cash Flow & Enterprise
FCF?$241.7M
Enterprise Value?$7.3B
Fundamentals ratios updated end of day